The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis

J. T. Kissel, R. K. Halterman, K. W. Rammohan and J. R. Mendell
Department of Neurology, Ohio State University, Columbus 43210.

Accumulating evidence indicates that a complement-mediated microvasculopathy may play a pathogenic role in dermatomyositis. In a previous study, we demonstrated neoantigens of the C5b-9 complement membrane attack complex in the muscle microvasculature of childhood and adult cases of dermatomyositis. To further characterize the relationship between the vascular complement deposits and histologic changes, quantitative histopathologic analyses were performed on 39 dermatomyositis biopsy specimens (26 adult, 13 children). There was a significant correlation between the percentage of fascicles with fibers having focal myofibrillar loss, a change seen early in the evolution of ischemic muscle fiber damage, and the percentage of fascicles having capillary deposits of membrane attack complex. Conversely, in biopsy specimens with a higher percentage of fascicles with perifascicular atrophy, membrane attack complex deposits were significantly less common. A fascicle-by-fascicle analysis supported these observations. Patients whose biopsy specimens were negative for microvascular membrane attack complex had clinical weakness for a significantly longer time than those patients with vascular complement deposits. These data support the hypothesis that the complement-mediated vasculopathy is a primary immunopathogenic event in the evolution of muscle lesions in dermatomyositis.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications
Greenberg
Neurology 2007;69:2008-2019.
ABSTRACT | FULL TEXT  

Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy
Osborne et al.
Neurology 2007;68:569-577.
ABSTRACT | FULL TEXT  

Diagnostic Significance of Membrane Attack Complex and Vitronectin in Childhood Dermatomyositis
Sakuta et al.
J Child Neurol 2005;20:597-602.
ABSTRACT  

Molecular profiles of inflammatory myopathies
Greenberg et al.
Neurology 2002;59:1170-1182.
ABSTRACT | FULL TEXT  

Myopathy with antibodies to the signal recognition particle: clinical and pathological features
Miller et al.
J. Neurol. Neurosurg. Psychiatry 2002;73:420-428.
ABSTRACT | FULL TEXT  

Gene Expression Profiling in DQA1*0501+ Children with Untreated Dermatomyositis: A Novel Model of Pathogenesis
Tezak et al.
J. Immunol. 2002;168:4154-4163.
ABSTRACT | FULL TEXT  

Complement Activation Promotes Muscle Inflammation during Modified Muscle Use
Frenette et al.
Am. J. Pathol. 2000;156:2103-2110.
ABSTRACT | FULL TEXT  

Expression of HLA Class I Antigens in Skeletal Muscle Is a Diagnostic Marker in Juvenile Dermatomyositis
Topaloglu et al.
J Child Neurol 1997;12:60-63.
ABSTRACT  

Cardiac and Central Nervous System Vasculitis in a Child With Dermatomyositis
Jimenez et al.
J Child Neurol 1994;9:297-300.
ABSTRACT  

Proton Magnetic Resonance Imaging and Spectroscopic Studies of the Pathogenesis and Treatment of Juvenile Dermatomyositis
Slopis et al.
J Child Neurol 1993;8:242-249.
ABSTRACT